Skip to main content
NVDA-2.41%AAPL+3.21%GOOGL+0.58%MSFT-0.25%AMZN-0.28%TSM-1.35%SPCX+0.05%AVGO-0.64%META-1.57%TSLA-0.97%SKHY-4.36%MU-4.38%BRK-B-0.11%LLY0.00%JPM-0.50%WMT-0.08%AMD-2.96%V-0.18%XOM+0.61%ASMLa-1.66%JNJ-0.19%INTC-4.87%MA-0.57%0700.HK-1.94%1398.HK+0.79%ORCL-4.73%ABBV+1.14%BAC-0.31%CSCO-1.46%CVX-0.41%COST-0.24%KO+0.52%LRCX-4.97%CAT-1.49%AP2d-1.55%0005.HK-0.78%AMAT-2.59%UNH-0.91%HSBA.L-1.30%DELL-3.79%PG+0.27%MS-0.94%GE-0.66%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.20%HD-1.70%0939.HK+1.66%GS-1.09%NZDJPY-2.63%AUDJPY-1.87%CHFJPY-1.61%NZDCAD-1.45%EURNZD+1.44%NZDUSD-1.43%GBPNZD+1.38%GBPJPY-1.26%EURJPY-1.24%USDJPY-1.23%CADJPY-1.20%NZDCHF-1.06%USDZAR+1.05%USDNOK+0.90%USDSEK+0.88%EURZAR+0.86%AUDNZD+0.79%GBPZAR+0.78%EURNOK+0.71%USDTHB+0.70%AUDCAD-0.70%EURSEK+0.69%AUDDKK-0.66%AUDUSD-0.65%EURAUD+0.64%GBPAUD+0.59%USDMXN+0.56%AUDSGD-0.56%CHFNOK+0.56%CHFSEK+0.54%USDPLN+0.45%NZDSGD-0.42%GBPTRY+0.41%CADCHF+0.40%USDCHF+0.40%NOKJPY-0.38%EURCHF+0.37%GBPCHF+0.34%GBPHKD+0.32%USDSGD+0.29%GBPMXN-0.28%AUDCHF-0.26%EURPLN+0.26%SGDJPY+0.22%EURHKD-0.19%USDDKK+0.19%NZDMXN-0.17%USDILS+0.16%USDTRY+0.11%USDCNH+0.10%EURSGD+0.10%GBPCAD-0.08%EURCZK-0.07%PLNJPY+0.07%EURCNH-0.06%CHFSGD-0.05%AUDNOK+0.04%EURCAD-0.04%EURGBP+0.04%USDCOP-0.04%GBPUSD-0.04%EURUSD-0.02%USDCAD-0.02%USDHKD+0.02%GBPSGD+0.02%EURDKK0.00%XPTUSD-6.08%UKOIL+5.66%USOIL+5.54%XAGUSD-5.36%GAGUSD-5.36%HG1-4.86%XAUUSD-1.73%GAUUSD-1.73%XNGUSD+1.54%COTTON0.00%SUGAR0.00%S10.00%BTCUSD-1.51%ETHUSD-0.18%USDTUSD-0.02%XRPUSD-3.01%SOLUSD-1.77%TRXUSDT+0.15%ZECUSDT-9.53%DOGEUSD-2.71%XMRUSDT+0.59%LINKUSD-1.57%XLMUSD-1.49%BCHUSDT-9.87%LTCUSD-1.60%UNIUSD-1.34%TONUSD+24.88%HBARUSDT-2.23%SUIUSD-4.46%TAOUSDT-5.65%AAVEUSD-2.40%DOTUSDT-2.01%ICPUSDT-1.12%ONDOUSDT-3.48%WLDUSDT-3.39%ATOMUSDT-3.41%ARBUSDT-0.56%JUPUSDT-3.82%INJUSDT-2.40%STXUSDT-4.53%FETUSDT-3.21%TIAUSDT-1.13%PYTHUSDT-1.52%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.77%WIFUSDT-5.87%OPUSDT-4.00%POLUSDT-4.76%IOTAUSDT-4.23%AXSUSDT-2.47%FARTCOINUSDT-3.11%EOSUSDT-2.91%DYDXUSDT-2.57%ORDIUSDT-0.84%GALAUSDT-3.09%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.41%AAPL+3.21%GOOGL+0.58%MSFT-0.25%AMZN-0.28%TSM-1.35%SPCX+0.05%AVGO-0.64%META-1.57%TSLA-0.97%SKHY-4.36%MU-4.38%BRK-B-0.11%LLY0.00%JPM-0.50%WMT-0.08%AMD-2.96%V-0.18%XOM+0.61%ASMLa-1.66%JNJ-0.19%INTC-4.87%MA-0.57%0700.HK-1.94%1398.HK+0.79%ORCL-4.73%ABBV+1.14%BAC-0.31%CSCO-1.46%CVX-0.41%COST-0.24%KO+0.52%LRCX-4.97%CAT-1.49%AP2d-1.55%0005.HK-0.78%AMAT-2.59%UNH-0.91%HSBA.L-1.30%DELL-3.79%PG+0.27%MS-0.94%GE-0.66%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.20%HD-1.70%0939.HK+1.66%GS-1.09%NZDJPY-2.63%AUDJPY-1.87%CHFJPY-1.61%NZDCAD-1.45%EURNZD+1.44%NZDUSD-1.43%GBPNZD+1.38%GBPJPY-1.26%EURJPY-1.24%USDJPY-1.23%CADJPY-1.20%NZDCHF-1.06%USDZAR+1.05%USDNOK+0.90%USDSEK+0.88%EURZAR+0.86%AUDNZD+0.79%GBPZAR+0.78%EURNOK+0.71%USDTHB+0.70%AUDCAD-0.70%EURSEK+0.69%AUDDKK-0.66%AUDUSD-0.65%EURAUD+0.64%GBPAUD+0.59%USDMXN+0.56%AUDSGD-0.56%CHFNOK+0.56%CHFSEK+0.54%USDPLN+0.45%NZDSGD-0.42%GBPTRY+0.41%CADCHF+0.40%USDCHF+0.40%NOKJPY-0.38%EURCHF+0.37%GBPCHF+0.34%GBPHKD+0.32%USDSGD+0.29%GBPMXN-0.28%AUDCHF-0.26%EURPLN+0.26%SGDJPY+0.22%EURHKD-0.19%USDDKK+0.19%NZDMXN-0.17%USDILS+0.16%USDTRY+0.11%USDCNH+0.10%EURSGD+0.10%GBPCAD-0.08%EURCZK-0.07%PLNJPY+0.07%EURCNH-0.06%CHFSGD-0.05%AUDNOK+0.04%EURCAD-0.04%EURGBP+0.04%USDCOP-0.04%GBPUSD-0.04%EURUSD-0.02%USDCAD-0.02%USDHKD+0.02%GBPSGD+0.02%EURDKK0.00%XPTUSD-6.08%UKOIL+5.66%USOIL+5.54%XAGUSD-5.36%GAGUSD-5.36%HG1-4.86%XAUUSD-1.73%GAUUSD-1.73%XNGUSD+1.54%COTTON0.00%SUGAR0.00%S10.00%BTCUSD-1.51%ETHUSD-0.18%USDTUSD-0.02%XRPUSD-3.01%SOLUSD-1.77%TRXUSDT+0.15%ZECUSDT-9.53%DOGEUSD-2.71%XMRUSDT+0.59%LINKUSD-1.57%XLMUSD-1.49%BCHUSDT-9.87%LTCUSD-1.60%UNIUSD-1.34%TONUSD+24.88%HBARUSDT-2.23%SUIUSD-4.46%TAOUSDT-5.65%AAVEUSD-2.40%DOTUSDT-2.01%ICPUSDT-1.12%ONDOUSDT-3.48%WLDUSDT-3.39%ATOMUSDT-3.41%ARBUSDT-0.56%JUPUSDT-3.82%INJUSDT-2.40%STXUSDT-4.53%FETUSDT-3.21%TIAUSDT-1.13%PYTHUSDT-1.52%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.77%WIFUSDT-5.87%OPUSDT-4.00%POLUSDT-4.76%IOTAUSDT-4.23%AXSUSDT-2.47%FARTCOINUSDT-3.11%EOSUSDT-2.91%DYDXUSDT-2.57%ORDIUSDT-0.84%GALAUSDT-3.09%NOTUSDT-2.97%RONINUSDT-2.64%
KM

Kestra Medical Technologies, Ltd. (KMTS)

NASDAQ • Healthcare

$24.07
-$1.57 (-6.1%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$25.32
Previous Close$24.07
Day Range$24.03 - $25.57
Avg. Volume (3M)260.7K
Market Cap$1.4B
52 Week Range
$17.34$30
Next EarningsIn 4 daysSep 14, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$28.6M100%
Gross Profitminus cost of goods$15.6M55%

Fundamentals & Financials

Revenue (TTM)
$95.1M
Net Income (TTM)
-$131.6M
EPS (TTM)
-$2.42
ROA (TTM)
-36.72%
Current Ratio
4.41
Dividend Yield
0.025%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-4.4%Q4 2025-$0.62
-1.7%Q1 2026-$0.61
-13.6%Q3 2026-$0.67
Next

Sep 14

in 4 daysQ3 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Miss -13.6%

Kestra Medical Technologies’ preliminary fiscal fourth-quarter 2026 results topped consensus on revenue but trailed on EPS, as reported July 14, 2026. Revenue rose 66.2% to about $28.6 million (up from about $17.2 million a year ago), with the quarter’s scale showing up in gross profit of roughly $15.7 million and gross margin of about 55%. Operating costs continued to outweigh the revenue base, with operating income of around -$39.3 million and operating margin of about -137%. Net income was roughly -$38.8 million, improving 25.4% year over year from about -$52.1 million. On the tape, revenue of $28.6 million topped the $26.5 million estimate, +8%, while EPS of -$0.67 trailed the -$0.59 estimate by -$0.08. Cash flow remained negative, with negative operating cash flow of about $18.7 million, and the company paid roughly $0.3 million in dividends. Next-period consensus calls for EPS of -$0.62 on revenue of $29.0 million.

Next report — what to expect

Kestra Medical Technologies, Ltd. (KMTS) reports on September 14, 2026. Wall Street is looking for EPS of -$0.616 on revenue of $29.0 million. For trailing context, revenue grew +66.2% year over year last quarter. KMTS has beaten EPS in 1 of its 6 most recent quarters.

View full earnings history

About Kestra Medical Technologies, Ltd.

Kestra Medical Technologies, Ltd. develops cardiac care devices and related services for the healthcare market, with a focus on wearable technologies and connected patient management. Listed on the NASDAQ as KMTS, the company generated $95.1 million in FY2026 revenue from medical instruments and supplies used in cardiac monitoring and treatment.

Name
Kestra Medical Technologies, Ltd.
CEO
Brian Webster
Website
kestramedical.com
Industry
Healthcare
Year Founded
2014
Employees
443

Today's Snapshot

AI-generated

So far today, KMTS is trading 1.8% lower at 23.64, in line with a weaker sector. Kestra Medical Technologies appointed Daniel Finney as vice president of research and development. KMTS is due to report earnings on 14 September.

Trading Volume

Below 10d avg (246.7K)

166.7K

vs S&P 500 Today

Underperforming Market

-1.20%

Updated: September 10, 2026 at 19:10 UTC

Technical Indicators

1 Buy1 Neutral6 Sell
KMTS shows clear short- to medium-term weakness as price is beneath the 10- and 20-period averages and below the day’s VWAP, which supports the sell view. Momentum readings are skewed negative with a deep CCI and a slightly bearish MACD while RSI sits in lower territory, and volume measures are unfavorable with OBV pointing down. Trend strength is limited, as ADX remains low, but intraday pressure is reinforced by an above-average ATR. Technical takeaway: Sell.
All signals
  • EMA (5 indicators)$24.17 - $25.58
    Sell
  • RSI (14)36.92
    Neutral
  • Stochastic %K (14, 3, 3)11.25
    Buy
  • MACD Level (12, 26)-0.25
    Sell

Peers & Related Assets

PLSEPulse Biosciences, Inc.
$52.97+8.6%
NEOGNeogen Corporation
$11.92+0.3%
PGENPrecigen, Inc.
$6.8-1.0%
NVCRNovocure Ltd
$15.63-7.2%
BLFSBioLife Solutions, Inc.
$34.93-1.3%
AZTAAzenta, Inc.
$30.15-2.2%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.